A Study to Describe the Efficacy of Diphereline Following Conservative Surgery in Deep Infiltrating Endometriosis (DIE) Patients Over a Period of 24 Months

Exclusion Criteria

• •Pregnancy or lactation.
• •Patients currently on treatment or who have been on therapy with a GnRHa in the last 6 months.
• •Premenopausal women who may reach menopause within the 3 years post randomisation.
• •Hypersensitivity to Triptorelin or one of the excipients of Triptorelin 3.75mg
• •Treatment with another research drug over the last 3 months before the study
• •Potentially unreliable patients, and those judged by the investigator to be unsuitable for the study.